400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / PI3K/Akt/mTOR / PI3K / GSK1059615
CAS No.: 958852-01-2
GSK1059615 is a dual inhibitor of PI3Kα/β/δ/γ (reversible) and mTOR with IC50 of 0.4 nM/0.6 nM/2 nM/5 nM and 12 nM
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00695448 | Solid Tumours | Phase 1 | Terminated(This study was term... more >>inated prematurely due to lack of sufficient exposure following single- and repeat-dosing.) Collapse << | - | United States, Tennessee ... more >> GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Collapse << |
实验方案
技术信息
CAS号 | 958852-01-2 | 储存条件 |
|
|
分子式 | C18H11N3O2S | 运输 | 蓝冰 | |
分子量 | 333.36 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00695448 | Solid Tumours | Phase 1 | Terminated(This study was term... more >>inated prematurely due to lack of sufficient exposure following single- and repeat-dosing.) Collapse << | - | United States, Tennessee ... more >> GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网